Resources
The work of the National Methadone Access and Quality Commission (NMAQC) is informed by a wide range of preexisting guidelines, studies, reports, and statements pertaining to the past, present, and future of methadone treatment in the United States. This page does not include the innumerable publications in the peer-reviewed academic literature that are relevant to the NMAQC’s work. Resources on this page are provided for informational purposes, and inclusion does not represent endorsement by the NMAQC or FORE.
Current Guidelines
Copy Link
Government Reports
Copy Link
Drug Enforcement Administration (DEA)
HHS Office of the Inspector General
- SAMHSA’s Oversight Generally Ensured That the Commission on Accreditation of Rehabilitation Facilities Verified That Opioid Treatment Programs Met Federal Opioid Treatment Standards (2021)
- States’ Use of Grant Funding for a Targeted Response to the Opioid Crisis (2020)
Government Accountability Office (GAO)
- Substance Use Disorder: Reliable Data Needed for Substance Abuse Prevention and Treatment Block Grant Program (2020)
- Opioid Addiction: Laws, Regulations, and Other Factors Can Affect Medication-Assisted Treatment Access (2016)
- Methadone-Associated Overdose Deaths: Factors Contributing to Increased Deaths and Efforts to Prevent Them (2009)
- Methadone Maintenance: Some Treatment Programs Are Not Effective; Greater Federal Oversight Needed (1990)
- Drug Abuse: Research on Treatment May Not Address Current Needs (1990)
National Institute on Drug Abuse (NIDA)
Professional Association Reports & Statements
Copy Link
American Association for the Treatment of Opioid Dependence (AATOD)
- Public Comment: Registration Requirements for Narcotic Treatment Programs with Mobile Components (2020)
- Integrated Service Delivery Models for Opioid Treatment Programs in an Era of Increasing Opioid Addiction, Health Reform, and Parity (2016)
- Technical Review of SAMHSA’s Final Regulations
- The Modernizing Opioid Treatment Access (MOTA) Act: Fact-Checking Sheet (2023)
American Academy of Addiction Psychiatry (AAAP)
- Public Comment: Modernizing Opioid Treatment Access Act (2022)
- Public Comment: Comments in Response to RIN 0930-AA39 Medications for the Treatment of Opioid Use Disorder (2023)
American Medical Association (AMA)
American Pharmacists Association (APhA)
American Society of Addiction Medicine (ASAM)
- The Modernizing Opioid Treatment Access Act: Putting the Patient, Not a Program, at the Center (joint with AMERSA, 2023)
- Reducing Federal Bureaucratic Barriers to Methadone for Opioid Use Disorder and Impowering State Innovation (2025)
Association for Multidisciplinary Research and Education on Substance use and Addiction (AMERSA)
Nonprofit and Advocacy Organization Reports, Statements, and Resources from Other Entities
Copy Link
- Liberating Methadone: A Roadmap for Change Conference Proceedings and Recommendations (National Coalition to Liberate Methadone, National Survivors Union, New York University Langone Center for Opioid Epidemiology and Policy, 2024)
- Methadone Treatment for Opioid Use Disorder: Improving Access Through Regulatory and Legal Change – Proceedings of a Workshop (National Academies of Medicine, 2022)
- Medication for Opioid Use Disorder Saves Lives (National Academies of SEM, 2019)
- Responding to the Opioid Crisis in North American and Beyond: Recommendations of the Stanford-Lancet Commission (The Lancet, 2022)
- The Methadone Manifesto (Methadone Monday Working Group, Urban Survivors Union, 2021)